OM stock icon

Outset Medical

0.8700 USD
-0.0351
3.88%
Updated Dec 3, 10:09 AM EST
1 day
-3.88%
5 days
-3.09%
1 month
40.23%
3 months
64.87%
6 months
-77.23%
Year to date
-84.57%
1 year
-84.71%
5 years
-98.57%
10 years
-98.57%
0
Funds holding %
of 6,780 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

2% more call options, than puts

Call options by funds: $57K | Put options by funds: $56K

35% less funds holding

Funds holding: 121 [Q2] → 79 (-42) [Q3]

51.27% less ownership

Funds ownership: 101.3% [Q2] → 50.02% (-51.27%) [Q3]

59% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 37

82% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 51

91% less capital invested

Capital invested by funds: $202M [Q2] → $17.6M (-$184M) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for OM.

Financial journalist opinion

Based on 4 articles about OM published over the past 30 days

Neutral
GlobeNewsWire
2 weeks ago
Outset Medical to Present at the 2024 Stifel Healthcare Conference
SAN JOSE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2024 Stifel Healthcare conference on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time.
Outset Medical to Present at the 2024 Stifel Healthcare Conference
Neutral
Seeking Alpha
3 weeks ago
Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript
Outset Medical Inc. (NASDAQ:OM ) Q3 2024 Results Conference Call November 6, 2024 5:00 PM ET Company Participants James Mazzola - Head of Investor Relations Leslie Trigg - President, CEO & Chairman Nabeel Ahmed - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Avi Kohn RBC - Capital Markets Suraj Kalia - Oppenheimer & Co Marie Thibault - BTIG Josh Jennings - TD Cowen Operator Good day, and thank you for standing by. Welcome to the 2024 Third Quarter Outset Medical Conference Call.
Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
3 weeks ago
Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.71 per share a year ago.
Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
3 weeks ago
Outset Medical Reports Third Quarter 2024 Financial Results
SAN JOSE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2024.
Outset Medical Reports Third Quarter 2024 Financial Results
Neutral
Accesswire
1 month ago
Contact Levi & Korsinsky by October 28, 2024 Deadline to Join Class Action Against Outset Medical, Inc.(OM)
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109746&wire=1 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by October 28, 2024 Deadline to Join Class Action Against Outset Medical, Inc.(OM)
Neutral
Accesswire
1 month ago
Investors in Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109727&wire=1 or contact Joseph E. Levi, Esq.
Investors in Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM
Neutral
Accesswire
1 month ago
Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - OM
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109608&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - OM
Neutral
Accesswire
1 month ago
FINAL OM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Outset Medical, Inc. Investors to Join the Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company") (NASDAQ:OM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Outset Medical securities between September 15, 2020, and August 7, 2024, inclusive (the "Class Period").
FINAL OM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Outset Medical, Inc. Investors to Join the Class Action Lawsuit!
Neutral
PRNewsWire
1 month ago
Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - OM
NEW YORK , Oct. 28, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Outset Medical, Inc. (NASDAQ: OM). Shareholders who purchased shares of OM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - OM
Neutral
Accesswire
1 month ago
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM
NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:OM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM
Charts implemented using Lightweight Charts™